Latest news about Beryl Drugs
Beryl Drugs Reports Q1 Net Profit of Rs 2.11 Lakhs Amid Partial Manufacturing Suspension Aug 07, 2025
Beryl Drugs Limited announced a turnaround to profitability for Q1 ended June 30, with a net profit of Rs 2.11 lakhs compared to a net loss of Rs 36.79 lakhs in the previous year's Q1. Revenue from operations increased to Rs 483.58 lakhs from Rs 287.73 lakhs. The company's manufacturing facility is partially under suspension and upgradation, impacting the turnover for the entire quarter. Despite this, Beryl Drugs improved its financial performance significantly. Total expenses decreased to Rs 476.61 lakhs, and earnings per share stood at Rs 0.04.